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Abstract
Background: In a large randomised trial in patients with seasonal allergic rhinitis (SAR), acupuncture was superior
compared to sham acupuncture and rescue medication. The aim of this paper is to describe the characteristics of
the trial’s participating physicians and to describe the trial intervention in accordance with the STRICTA (Standards
for Reporting Interventions in Controlled Trials of Acupuncture) guidelines, to make details of the trial intervention
more transparent to researchers and physicians.
Methods: ACUSAR (ACUpuncture in Seasonal Allergic Rhinitis) was a three-armed, randomised, controlled
multicentre trial. 422 SAR patients were randomised to semi-standardised acupuncture plus rescue medication (RM,
cetirizine), sham acupuncture plus RM or RM alone. We sent a questionnaire to trial physicians in order to evaluate
their characteristics regarding their education about and experience in providing acupuncture. During the trial,
acupuncturists were asked to diagnose all of their patients according to Chinese Medicine (CM) as a basis for the
semi-standardised, individualized intervention in the acupuncture group. Every acupuncture point used in this trial
had to be documented after each session
Results: Acupuncture was administered in outpatient clinics by 46 (mean age 47 ± 10 years; 24 female/ 22 male)
conventionally-trained medical doctors (67% with postgraduate specialization such as internal or family medicine)
with additional extensive acupuncture training (median 500 hours (1st quartile 350, 3rd quartile 1000 hours with
73% presenting a B-diploma in acupuncture training (350 hours)) and experience (mean 14 years in practice). The
most reported traditional CM diagnosis was ‘wind-cold invading the lung’ (37%) and ‘wind-heat invading the lung’
(37%), followed by ‘lung and spleen qi deficiency’ (9%). The total number of needles used was higher in the
acupuncture group compared to the sham acupuncture group (15.7 ± 2.5 vs. 10.0 ± 1.6).
Conclusions: The trial interventions were provided by well educated and experienced acupuncturists. The different
number of needles in both intervention groups could be possibly a reason for the better clinical effect in SAR
patients. For future trials it might be more appropriate to ensure that acupuncture and sham acupuncture groups
should each be treated by a similar number of needles.
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Background
Over the past decade an increasing number of randomised
controlled trials have been conducted to determine the
efficacy or effectiveness of acupuncture in patients with
allergic rhinitis. As shown by previous systematic reviews
of acupuncture for the treatment of allergic rhinitis, the
evidence on the specific effects of acupuncture is still
inconclusive [1,2]. The trials included in those reviews
have suffered from a variety of methodological limitations,
such as small patient numbers or the lack of a sham-
acupuncture control group.
In the randomised multicentre ACUpuncture in Seasonal
Allergic Rhinitis (ACUSAR) trial, we investigated whether
a semi-standardised acupuncture intervention plus rescue
medication (RM) was more effective than standardised
sham acupuncture plus RM or RM alone in patients
with seasonal allergic rhinitis (SAR). The ACUSAR was
the first acupuncture trial funded by the German Re-
search Foundation (Deutsche Forschungsgemeinschaft,
DFG). The DFG had requested a randomised trial includ-
ing a sham control and a hierarchical test procedure with
a non-inferiority and superiority procedure primarily for
the comparison of acupuncture with sham acupuncture.
The protocol and primary results have been published
elsewhere [3,4].
In 2001 the STRICTA (Standards for Reporting Inter-
ventions in Controlled Trials of Acupuncture) guidelines
were published to encourage more precise descriptions of
the interventions used in controlled trials of acupuncture
in publications and to improve the quality of these inter-
ventions [5]. The aim of this paper is to describe the char-
acteristics of the trial’s participating physicians, to describe
the trial intervention in accordance with the STRICTA
(Standards for Reporting Interventions in Controlled Trials
of Acupuncture) guidelines and to make details of the
trial intervention more transparent to researchers and
physicians.
Methods
The ACUSAR trial was a randomised, controlled multi-
centre trial comparing acupuncture (Acu) plus rescue
medication (RM) with non-penetrating sham acupuncture
(Sham) plus RM and with RM alone in the treatment of
SAR. Main inclusion criteria were SAR diagnosed by an
allergist; IgE positivity to grass and birch pollen; age 16
to 45 years; no contraindications to cetirizine as anti-
allergy medication; and ability to complete a symptom
diary, including recording RM use. Main exclusion criteria
were perennial AR, allergic asthma, moderate to severe
atopic dermatitis, autoimmune disorders, severe chronic
inflammatory diseases, specific immunotherapy during the
past 3 years or planned in the next 2 years, previous
acupuncture treatment for SAR, and any CAM use.
Patients were centrally randomised (ratio 2:1:1) in blocks
of 8 to one of the three treatment groups. The random-
isation schedule was generated using DatInf RandList,
version 1.2 (DatInf, Tübingen, Germany) at the University
of Hamburg, Hamburg, Germany. An independent clinical
trials unit (KKS Charite’) implemented the allocation
schedule using a centralised telephone randomisation pro-
cedure. Patients, trial statisticians, outcome assessors, data
entry personnel, and the funder were blinded to treatment
assignment throughout the trial. This trial followed the
Declaration of Helsinki Good Clinical Practice guidelines
(ICH-GCP) for trial conduct and included an external
audit. All trial participants provided written informed con-
sent and were not reimbursed for participating in the trial.
The trial protocol was approved by the appropriate ethical
review boards (ethics commissions and reference num-
bers: Charité- Universitätsmedizin Berlin: EA1/214/07;
Landesärztekammer Bavaria: 7/08030; Landesärztekammer
Brandenburg: AS(18)a/2008; Technical University Dresden
Faculty of Medicine Carl Gustav Carus: EK315122008;
Essen University Hospital: 08–3610; Jena University Hos-
pital: 2248-03/08; Medical faculty Ludwig-Maximilian-
University München: 105–08).
Trial physicians
The participating physicians were recruited in a manner
designed to ensure that their qualifications were adequate
to perform a treatment procedure which included a CM
diagnosis before acupuncture. According to the trial
protocol [3], trial physicians had to fulfil the following
criteria: (1) acupuncture training of at least 140 hours
(equals an ‘A-diploma’ from the major German acu-
puncture associations); (2) at least 3 years of practical
experience with acupuncture; (3) 50% of participating
physicians had to have at least 350 h of acupuncture
training (equals ‘B-diploma’); (4) 50% of trial physicians
had to have experience working in clinical studies; and
(5) required participation in trial training sessions on
trial methods, applied trial interventions, and standards
for performing clinical trials (ICH-GCP). At the trial
beginning of the trial we sent a questionnaire to all 46
trial physicians. This questionnaire included 14 items on
their medical background and training such as medical
specialisation, scope of training as acupuncturist, time
working as acupuncture specialist, qualification as trainer
for acupuncture, CM diagnostic procedures, etc.
CM syndrome diagnosis and trial intervention
To find a consensus on the treatment regime for both the
acupuncture as well as the penetrating sham acupuncture
group, we performed a Delphi consensus procedure [6].
Five experts from two major German acupuncture asso-
ciations, the German Medical Acupuncture Association
(Deutsche Ärztegesellschaft für Akupunktur; DÄGfA)
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Munich (n = 3), and the International Society for CM
(Societas Medicinae Sinensis, SMS) (n = 2) Munich, partic-
ipated in this consensus group and discussed the treat-
ment regime with three experts on trial methodology and
statistics in two onsite meetings and one written round. A
consensus between the need for standardisation and indi-
vidualisation was found in using a semi-standardised treat-
ment in the acupuncture group.
The consensus procedure revealed the following result:
Acupuncturists were requested to diagnose all their pa-
tients according to CM and to document the individual
syndrome diagnosis for each patient from a given sample of
possible diagnoses as the basis for an individualized, semi-
standardised treatment in the acupuncture group [7].
Both the acupuncture and sham acupuncture treatments
consisted of 12 sessions of 30 minutes’ duration adminis-
tered over a period of 8 weeks (preferably 2 sessions a
week for the first 4 weeks, followed by 1 session per week
for the remaining 4 weeks). Patients in the rescue medica-
tion group did not receive acupuncture treatment during
the first 8 weeks after randomisation; as of week 9, they
received the acupuncture treatment described below.
Acupuncture treatment was semi-standardised (Table 1):
All patients had to be treated at 4 obligatory basic acu-
puncture points: L. I. 4, L.I.11, L. I. 20 bilaterally and Ex-
HN3 (Yintang). Furthermore, at least 3 of 8 optional basic
acupuncture points had to be selected according to the
principles of CM. In addition, patients had to be treated
with at least 3 local and/or distant additional acupunc-
ture points. Acupuncturists were allowed to use additional
points including ear acupuncture points. Every acupunc-
ture point used in this trial had to be documented after
each session. Sterile and disposable single-use needles
were used. Their length and type had to be documented.
The treatment protocol aimed to produce the irradiating
needling sensation (‘de qi’) if possible, and the needles
were to be stimulated manually at least once in each
session.
The location of points was performed on the basis of
individual body size using measuring units equal to the
transverse width of finger (TF), or ‘cun’. One cun is
defined according to the traditional rules as the width of
the interphalangeal joint of patient’s thumb.
Penetrating sham acupuncture treatment entailed super-
ficially inserting fine needles (≤ 20 mm in length) at prede-
fined, distant non-acupuncture points bilaterally (Table 2).
These non-acupuncture points were not in the area of the
face or head to avoid any possible local effects for SAR
symptoms. The selection of at least 5 out of 7 points was
left to the physician. Physicians were instructed to avoid
manual stimulation of the needles and provocation of ‘de
qi’ in the sham acupuncture group. All participating trial
physicians received special training on how to apply this
penetrating sham acupuncture; the training included a
DVD that provided detailed instructions.
Patients in all three trial arms were permitted to take
up to two doses of cetirizine dihydrochloride/day. If SAR
symptoms were not adequately controlled with cetirizine,
participants could be treated with an oral corticosteroid.
The use of other anti-allergy medication was prohibited.
Patients were instructed to document the use of all anti-
allergy medications precisely in their diaries. Patients were
instructed not to use any of the following medications or
treatments during the trial period in both years: Topical
cromolyns (eye drops and nasal spray), topical antihista-
mines, topical steroids, leukotriene receptor antagonists,
anti-cholinergic agents, α-adrenergic agonists, allergen im-
munotherapy, nasal ipratropium, decongestants and any
form of complementary and alternative medicine (CAM)
for SAR. In particular, no moxibustion or other additional
complementary method was allowed.
All patients completed standardised questionnaires at
baseline and after 8, 16, and 52 weeks. In addition, pa-
tients filled in diaries during the first 8 weeks and during
weeks 14 to 16. Main outcome measures in the ACU-
SAR trial were the mean of the Rhinitis Quality of Life
Questionnaire (RQLQ) overall score [8] and the mean of
the Rescue Medication Score (RMS) [9] during the 7th
and 8th week after randomisation. Rescue medication
usage was scored daily using the RMS on a 4-point scale
as follows: no rhinitis medication (0 points); oral antihista-
mines – 1 × cetirizine 10 mg/day or equivalent (1 point);
Table 1 Acupuncture points used in the ACUSAR trial
Category of points Points Selection
Basic acupuncture points
(obligatory)
L.I. 4; L.I. 11; L.I. 20; EX-HN 3 YINTANG Bilateral (except YINTANG), all
together 7 points
Basic acupuncture points
(optional)
EX-HN 8 BITONG GB 20 LIV 3 LU 7 ST 36 SP 6 SJ 17 BL 13 Uni- or bilateral, at least 3 points
Additional local acupuncture
points (optional)
BL 2 GB 1, 14 EX-HN 5 TAIYANG SI 18, SJ 23 ST 2 Further points
At least 3 points (local and distant
additional points) uni- or bilateral
Additional distant acupuncture
points (optional)
LU 1, 5 ST 44 GB 41, 34, 37 LIV 2 LIV 5 KID 3, 7 BL 12, 20, 23, 26, 40 SP 9 REN
6, 17, 22, 20 SJ 5, 6 Further points
Additional ear acupuncture
(optional)
Allergy point Shenmen point Thymus point ACTH point Further points
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oral antihistamines – 2 × cetirizine 10 mg/day (=20 mg)
or equivalent, (2 points); any form of systemic steroids or
other drug for SAR (3 points). Patient questionnaire in-
cluded Visual Analogue Scales (VAS, 0–100 mm) for SAR
overall symptom severity and for nasal, eye, pharyngeal
and common symptoms, and the German version of the
health-related quality of life instrument Short Form-36
(SF-36) [10,11]. Sample size was calculated on RQLQ data
using nQuery Advisor, version 4.0, and assuming a power
of 80% and a common SD of 1.1. More details on sample
size calculation and statistical analyses have been pub-
lished elsewhere [4].
Results
Results of the ACUSAR trial have been published previ-
ously [4]. A total of 422 patients (Acu 212, Sham 102, RM
108; 60% female, 40% male; mean age 33 ± 8 years (SD)
were included between March and May in both 2008 and
2009 (see Figure 1). 46 specialized physicians in 6 hospitals
and 32 private outpatient clinics participated as trial
centres. The majority of physicians were located in
Bavaria (n = 21) and Berlin (n = 16) followed by North
Rhine-Westphalia (n = 5), Brandenburg (n = 3) and Sax-
ony (n = 1). Most centres recruited between 4 and 10
patients (n = 15), followed by centres that recruited
more than 20 (n = 9), two and three patients (n = 8), and
between 10 and 20 SAR patients (n = 6).
The characteristics of the 46 physicians providing
trial intervention are summarised in Table 3. They had
a median of 500 hours (range 140 to 2550 hours) of
acupuncture training before participating in the trial,
and 33 physicians (73%) had a ‘B - Diploma’. Sixteen
(36%) trial physicians had taught acupuncture in accre-
dited postgraduate courses. Physicians had used acupunc-
ture in their respective practices for an average of 14 (1 to
30) years and had treated a median of 150 (15 to 5,000)
patients and a median of 20 (0–550) SAR patients with
acupuncture in the year preceding trial participation.
Forty-four physicians (96%) stated that they frequently
(43%) or always (52%) make a CM syndrome diagnosis
before starting treatment.
A CM syndrome diagnosis was reported for all of the
422 patients who started the intervention (see Table 4).
In 334 cases (79%), one (27.2%) or two CM syndrome
diagnosis (51.4%) were reported. The most frequently
reported primary syndrome diagnoses were “wind-cold
invading the lung” and “wind-heat invading the lung”
(both 37%), which includes the differentiation of typical
symptoms for SAR such as nasal itching, sneezing, eye
itching, followed by ‘lung and spleen deficiency’ (9%) and
‘liver heat’ (8%) as underlying syndromes. The most docu-
mented CM syndrome combinations were ‘wind-cold’ and
‘wind-heat invading the lung’ (24%) and ‘wind-heat invad-
ing the lung’ and ‘lung and spleen deficiency’ (15%).
Patients in the acupuncture group were treated in a
total of 2.455 sessions. According to the protocol, all of
the patients were treated at obligatory and optional basic
acupuncture points. On average, 15.7 ± 2.5 (mean and
standard deviation) needles were used per session and
the mean duration of each acupuncture session was
24.4 ± 4.4 minutes. The number of needles per session
remained stable over the course of treatment. In almost
all patients (>93%), the ‘de qi’ sensation could be elicited,
and in most cases (>80%) manual stimulation was
Table 2 ACUSAR trial: treatment in the acupuncture group
All sessions Session 1 Session 6 Session 12
n = 1.145 n = 97 n = 96 n = 93
n (%)/mean±sd n (%)/mean±sd n (%)/mean±sd n (%)/mean±sd
Number of needles/session 10.0±1.6 10.0±1.6 10.0±1.5 9.9±1.5
Duration of sessions (minutes) 23.7±3.6 23.2±3.9 23.9±3.9 23.9±4.0
Length of needles used*
≤ 15 mm 675 (59.0) 47 (48.5) 57 (59.4) 57 (61.3)
15 to 21 mm 521 (45.5) 49 (50.5) 43 (44.8) 40 (43.0)
20 to 30 mm 11 (1.0) 3 (3.1) 1 (1.0) 1 (1.1)
Sham Acupuncture Points
- ‘Deltoideus’ 1.130 (98.4) 97 (100.0) 94 (97.9) 91 (97.9)
- ‘Upper Arm’ 1.079 (94.2) 93 (95.9) 90 (93.8) 87 (93.6)
- ‘Upper Thigh I’ 1.037 (90.5) 87 (89.7) 87 (90.6) 84 (90.3)
- ‘Upper Thigh II’ 1.011 (88.2) 89 (91.8) 84 (87.5) 81 (87.1)
- ‘Upper Thigh III’ 1.019 (88.9) 88 (90.7) 85 (88.5) 82 (88.2)
- ‘Back I’ 320 (27.9) 24 (24.7) 28 (29.2) 26 (28.0)
- ‘Back II’ 186 (16.2) 12 (12.4) 17 (17.7) 15 (16.1)
* More than one answer possible.
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performed once. Length of needles used was in most
cases a combination of 21 to 30 mm (84%) and ≤ 20 mm
(73%). All basic obligatory points were used in 97% of
cases, L.I. 4 and L.I. 11 were used in 100% of cases. Basic
optional acupuncture points used most frequently were
GB 20, LIV 3, ST 36, LU 7 and SP 6. For the optional
basic acupuncture points, more than 3 acupuncture
needles were used in 95% of cases. Additional local and
distant acupuncture points were used in 63% and 81% of
cases. In 39% of cases, additional ear acupuncture points
were used (see Table 5).
Patients in the sham acupuncture group were treated in
a total of 1.145 sessions due to the 2:1:1 randomisation
(see Table 6). On average, 10.0 ± 1.6 (mean and standard
deviation) needles were used per session and the mean
duration of each acupuncture session was 23.7 ± 3.6 mi-
nutes. Length of needles used solely or in combination
was ≤ 15 mm (59%) and 15 to 21 mm (46%). The most fre-
quently used sham acupuncture points were ‘Deltoideus’,
‘Upper Arm’, ‘Upper Thigh I’, ‘Upper Thigh II’, and ‘Upper
Thigh III’.
In the first 8 weeks, the proportion of patients who
used 10 mg and/or 20 mg cetirizine was 71% in the
acupuncture group, 76% in the sham acupuncture
group, and 83% in the RM group. Oral steroids were
used by 3 patients, one in each group. Altogether 27
patients (16 acupuncture, 4 sham acupuncture and 7
RM) took anti-allergy medication (mostly topical
steroids and cromoglicic acid, intake less than 12 days)
not permitted in the trial.
Discussion
Our analyses demonstrate that the physicians partici-
pating in the ACUSAR trial were a heterogeneous group
whose overall qualifications included extensive acu-
puncture training and long-term acupuncture experi-
ence that clearly exceeded not only the qualification
required for trial participation but also the qualification
Figure 1 ACUSAR trial: patients’ flow chart.
Ortiz et al. BMC Complementary and Alternative Medicine 2014, 14:128 Page 5 of 10
http://www.biomedcentral.com/1472-6882/14/128
of 200 h acupuncture training required for the German
statutory reimbursement of acupuncture treatment [12].
In addition, our data indicate that the consensus-based
treatment protocol used for acupuncture and sham
acupuncture in this trial was a feasible and successful
approach. Finally, in the ACUSAR trial, acupuncture
plus RM led to improvements in disease-specific quality
of life and reduction of antihistamine intake after
8 weeks of treatment compared to sham acupuncture
plus RM and to RM alone in SAR patients [4].
High quality randomised trials of acupuncture com-
pared to usual care or sham acupuncture are urgently
needed to evaluate both the effectiveness and efficacy of
this widely used CM intervention for various indica-
tions including SAR. However, defining interventions in
randomised controlled acupuncture trials represents a
challenging task. From a strictly scientific point of view,
standardised interventions are needed so that the find-
ings of a trial can be reproduced independently. To
date, three trials [13-15] comparing acupuncture and
sham acupuncture interventions in SAR have been pub-
lished. In contrast to the negative trials of Williamson
and Magnusson, in our trial and in the other positive
trial from Xue [15], a semi-standardised and therefore a
more individualised acupuncture intervention based on
a CM syndrome diagnosis was used.
Table 3 ACUSAR trial: characteristics of participating trial
physicians and assessment of intervention (n=46)
Mean ±sd; median
(range) or n (%)
Number of acupuncture sessions/centre 64.5; 48 (12-174)
Number of acupuncture and sham
acupuncture sessions/centre 94.3; 72 (12-252)
Patients/Centre 6; 46 (27-69)
Age (years) 47±10; 46 (27-69)
Female 24 (52%)
Medical practice prior to study initiation (years) 20±11; 19 (1-46)
Postgraduate specialisation 31 (67%)
Postgraduate education
- In acupuncture 31 (67%)
- In naturopathy 19 (42%)
- In homeopathy 2 (4%)
Acupuncture B diploma (at least 350 hours of
training) 33 (73%)
Hours of acupuncture training 672±462; 500 (140-2550)
Teacher of acupuncture in accredited
postgraduate courses 16 (35%)
Use of acupuncture prior to study initiation (years) 14±7; 15 (1-30)
Participation in earlier clinical trials
- In general 34 (74%)
- On acupuncture 24 (52%)
- With randomisation 29 (63%)
- With sham or placebo acupuncture 21 (46%)
Membership in professional societies
- In total 38 (83%)
- German Medical Acupuncture Association
(DÄGfA) 16 (35%)
- International Society for Chinese Medicine
(SMS) 16 (35%)
- German Association for Acupuncture and
Neural Therapy (DGfAN) 4 (9%)
- In more than one acupuncture society 9 (20%)
- Others 10 (22%)
Patients treated with acupuncture by trial
physicians in the year before the trial:
- In total 420; 150 (15-5000)
- Patients with seasonal allergic rhinitis 58; 20 (0-550)
Therapies used in patients in everyday
practice (percentages)
- Acupuncture 41% (5-100%)
- Other Chinese Medicine therapies
(e.g. Chinese herbal medicine) 28% (1-95%)
- Other complementary therapies 23% (1-90%)
- Conventional medicine 41% (2-100%)
Chinese diagnosis before treatment
- Always 24 (52%)
- Frequently 20 (43%)
- Rarely 2 (4%)
- Never 0
Table 4 ACUSAR trial: Chinese medicine syndrome
diagnoses (n=422)
CM Diagnosis in ACUSAR
patients
n (%)
Patients with one CM diagnosis 117 (27.7)
Patients with two CM diagnoses 217 (51.4)
Patients with three CM diagnoses 88 (20.9)
CM syndromes TCM rank 1 TCM diagnoses
(n=422 patients) (n=815 diagnoses)
n (%) n (%)
‘Wind cold’ 156 (37.0) 221 (27.1)
‘Wind heat’ 155 (36.7) 238 (29.2)
‘Liver heat’ 33 (7.8) 105 (12.9)
‘Chronic heat, yin deficiency’ 16 (3.8) 37 (4.5)
‘Chronic heat in the lung’ 21 (5.0) 55 (6.7)
‘Lung and spleen qi deficiency’ 36 (8.5) 132 (16.2)
‘Yang deficiency in kidneys’ 5 (1.2) 27 (3.3)
Combined CM syndroms TCM rank 1
and 2
‘Wind cold’ & ‘wind heat in
the lung’
74 (24.3)
‘Wind heat’ & ‘lung and spleen qi’ 38 (12.5)
‘Wind cold’ & ‘lung and spleen qi’ 47 (15.4)
‘Wind heat’ & ‘liver heat’ 45 (14.8)
Others 101 (33.1)
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Acupuncture in Germany and elsewhere is applied in a
highly variable manner. Treatment is often individualised,
as many physicians and acupuncturists believe that this
results in the greatest effectiveness [16]. Because of this,
acupuncture trials that use strictly standardised interven-
tions might neither represent real treatment conditions
nor an adequate foundation for guiding health care policy
decisions on acupuncture treatment. In the ACUSAR trial,
as well as in our ART trials published previously [17-20],
we opted for a compromise that would ensure a funda-
mental degree of consistency while at the same time
allowing some level of individualisation with regard to
point selection. The pre-published treatment protocol
was developed as part of a consensus process involving
Table 5 ACUSAR trial: treatment in the acupuncture group
All sessions Session 1 Session 6 Session 12
n = 2.455 n = 210 n = 205 n = 201
n (%)/mean±sd n (%)/mean±sd n (%)/mean±sd n (%)/mean ±sd
Number of needles/session 15.7±2.5 15.7±2.5 15.8±2.5 15.7±2.7
Duration of session (min) 24.4±4.4 24.3±4.5 24.5±4.6 24.6±4.7
Length of needles used*
≤ 20 mm 1.784 (72.7) 156 (72.9) 151 (73.7) 147 (73.1)
21 to 30 mm 2.053 (83.6) 171 (81.4) 173 (84.4) 162 (81.0)
31 to 40 mm 846 (34.5) 70 (33.3) 70 (34.2) 75 (37.5)
≥ 40 mm 103 (4.2) 10 (4.8) 9 (4.4) 10 (5.0)
Manual stimulation
- None 259 (10.5) 16 (7.6) 25 (12.2) 32 (16.0)
- Once 1.966 (80.1) 172 (81.9) 162 (79.0) 152 (76.0)
- More than once 230 (9.4) 22 (10.5) 18 (8.8) 16 (8.0)
De qi
- Easy to elicit 2.276 (92.9) 186 (88.6) 191 (93.2) 189 (94.5)
- Difficult to elicit 169 (6.9) 23 (11.0) 14 (6.9) 10 (5.0)
- Could not be elicited 10 (0.4) 1 (0.5) 0 1 (0.5)
Basic points (obligatory and optional) Needles/session 12.3±1.9 12.3±1.9 12.3±1.9 12.3±1.9
Basic obligatory points
- L.I.4 (right & left) 2.455 (100) 210 (100) 205 (100) 200 (100)
- L.I.11(right & left) 2.455 (100) 210 (100) 205 (100) 200 (100)
- L.I.20 (right & left) 2.412 (98.2) 206 (98.1) 201 (98.1) 198 (98.5)
- Ex-HN3 (Yintang) 2.432 (99.1) 208 (99.1) 203 (99.0) 199 (99.0)
- 7 Points used 2.378 (96.9) 205 (97.6) 198 (96.6) 194 (97.0)
Basic optional points
- GB20 (right & left) 1.567 (63.8) 131 (62.4) 131 (63.9) 129 (64.5)
- LIV3 (right & left) 1.253 (51.0) 138 (65.7) 136 (66.3) 133 (66.2)
- LU7 (right & left) 1.201 (48.9) 101 (48.1) 101 (49.3) 98 (49.0)
- ST36 (right & left) 1.478 (60.2) 126 (60.0) 123 (60.0) 121 (60.5)
- SP6 (right & left) 1.028 (41.9) 90 (42.9) 86 (42.0) 63 (41.5)
- SJ17 (right & left) 48 (2.0) 4 (1.9) 4 (2.0) 4 (2.0)
- BL13 (right & left) 204 (8.3) 17 (8.1) 17 (8.3) 17 (8.5)
- Ex-HN8 (right & left) 474 (19.3) 40 (19.1) 40 (19.5) 40 (19.4)
- Points used >=3 2.343 (95.4) 199 (94.8) 196 (95.6) 191 (95.5)
Additional optional points Needles/session 3.5 ± 1.9 3.5 ± 1.9 3.5 ± 1.9 3.5 ± 1.9
- Local (sessions) 1.550 (63.1) 131 (62.4) 129 (62.9) 128 (63.7)
- Distant (sessions) 1.991 (81.1) 169 (80.5) 167 (81.5) 162 (81.0)
- Points used>=2 2.292 (94.5) 198 (94.3) 194 (94.6) 190 (94.5)
Additional ear acupuncture 967 (39.4) 82 (39.1) 81 (39.5) 78 (39.0)
*More than one answer possible.
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leading experts from two German medical acupuncture
societies. The approach to medical acupuncture in
Germany is, in general, based more on the theories of
CM. We think that our pragmatic intervention ap-
proach is consistent with the theory of CM and may
yield better results in patients with SAR than a strictly
standardized acupuncture. However, we cannot rule out
that our trial may have resulted in different outcomes if
we had used a different acupuncture intervention in the
acupuncture and sham acupuncture groups.
The authors of another large trial that included 238
persistent allergic rhinitis patients and compared acu-
puncture with both sham-acupuncture and waiting list
published their results in 2013 [21]. Similar to our trial,
patients were treated with 12 acupuncture sessions in-
cluding a penetrating procedure for the sham acupunc-
ture. In contrast to the ACUSAR trial, the acupuncture
intervention was strictly standardised using 10 defined
points including bilateral L.I.4, L.I.20, ST2, ST36 and uni-
lateral EX-HN3 (Yin Tang) and GV23. This trial yielded
positive results for the main outcome parameter, the Total
Nasal Symptom Score (TNSS) in favour of acupuncture
versus sham-acupuncture and usual care. However, the re-
sults of this trial, (unlike those in the ACUSAR trial), were
inconsistent, because the secondary outcome parameter
e.g., Total Non-Nasal Symptom Score (TNNSS) and the
Rhinitis Quality of Life (RQLQ) didn’t show positive
results for acupuncture compared to sham acupuncture.
It is noteworthy that in our trial the number of acu-
puncture points in the acupuncture group was on average
15.7 ± 2.5 and therefore different compared to the number
of acupuncture points in the sham acupuncture group,
which averaged 10.0 ± 1.6. Further, because the selection
of possible sham acupuncture points was smaller compared
to those points in the acupuncture treatment scheme, the
sham acupuncture scheme was even more standardised
than treatment in the acupuncture group. We are aware
that these differences, particularly the higher number of
needles in the acupuncture group, could explain the better
clinical effect in SAR patients. Although difficult in a
semi-standardised treatment, for future trials it might be
more appropriate to ensure that acupuncture and sham
acupuncture groups are each treated by a similar number
of needles.
Even more difficult than defining the acupuncture
intervention itself is the choice of an appropriate sham
control. The German Research Foundation (DFG) re-
quested that our trial include a ‘sham’ or ‘placebo’ condi-
tion to investigate whether the effects of acupuncture
are specific. However, the concepts of ‘placebo’ and ‘spe-
cific effects’ are unclear in relation to acupuncture [22].
Although it is widely accepted in CM that it is important
to correctly locate points, it should be noted that this
theory has yet to be proved. Indeed, other aspects of
acupuncture treatment, such as skin penetration, depth
of needling, manipulation of needles, etc., may also be
relevant effect modifiers. In the absence of an inert and
indistinguishable placebo, a wide variety of sham inter-
ventions have been used in acupuncture trials. Based on
a systematic review of such interventions [23], as well as
on our consensus procedure with acupuncture experts,
we decided to use ‘sham’ acupuncture [24] as a sham
control. It differed from the ‘full’ or ‘true’ acupuncture
intervention with regard to point location, needling
Table 6 ACUSAR trial: treatment in the sham acupuncture group
All sessions Session 1 Session 6 Session 12
n = 1.145 n = 97 n = 96 n = 93
n (%)/mean±sd n (%)/mean±sd n (%)/mean±sd n (%)/mean±sd
Number of needles/session 10.0±1.6 10.0±1.6 10.0±1.5 9.9±1.5
Duration of sessions (minutes) 23.7±3.6 23.2±3.9 23.9±3.9 23.9±4.0
Length of needles used*
≤ 15 mm 675 (59.0) 47 (48.5) 57 (59.4) 57 (61.3)
15 to 21 mm 521 (45.5) 49 (50.5) 43 (44.8) 40 (43.0)
20 to 30 mm 11 (1.0) 3 (3.1) 1 (1.0) 1 (1.1)
Sham acupuncture points
- ‘Deltoideus’ 1.130 (98.4) 97 (100.0) 94 (97.9) 91 (97.9)
- ‘Upper Arm’ 1.079 (94.2) 93 (95.9) 90 (93.8) 87 (93.6)
- ‘Upper Thigh I’ 1.037 (90.5) 87 (89.7) 87 (90.6) 84 (90.3)
- ‘Upper Thigh II’ 1.011 (88.2) 89 (91.8) 84 (87.5) 81 (87.1)
- ‘Upper Thigh III’ 1.019 (88.9) 88 (90.7) 85 (88.5) 82 (88.2)
- ‘Back I’ 320 (27.9) 24 (24.7) 28 (29.2) 26 (28.0)
- ‘Back II’ 186 (16.2) 12 (12.4) 17 (17.7) 15 (16.1)
*More than one answer possible.
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depth, and the avoidance of ‘de qi’ and manual needle
stimulation. Similar interventions have been used in a
variety of previously published trials including all ART tri-
als [18,19,23]. We think a pragmatic comparison between
an acupuncture treatment lege artis and a form that is
clearly not following standard acupuncture theory and
practice appears to be an acceptable compromise.
In contrast to the other acupuncture trials, physicians
in our study were asked to provide a CM syndrome
diagnosis for all patients. This was a basis for the semi-
standardised, individualized intervention in the acu-
puncture group. The most frequent syndrome diagnoses
in SAR patients included in the trial were ‘wind-cold in-
vading the lung’ and ‘wind-heat invading the lung’. This
distribution of syndromes in SAR patients corresponds
with the statements of available textbooks on the sub-
ject [7,25]. Several acupuncture points are possible for
the treatment of these syndromes. Textbooks recom-
mend points like inter alia L.I.4, L.I. 11, LU 7, GB 20, SP
6, ST 36, LIV 3 which were respectively obligatory or
the most chosen optional points in ACUSAR. Only the
Xue [15] trial included an obligatory syndrome differen-
tiation and it is interesting to discover that Xue used a
slightly modified syndrome differentiation more focused
on the CM organ system rather than on the physiopa-
thology of the CM syndrome.
Conclusion
In conclusion, ACUSAR trial interventions were provided
by well educated and experienced acupuncturists and con-
tained more needles in the acupuncture group compared
to the sham acupuncture group. For future trials, it might
be more appropriate to ensure that acupuncture and sham
acupuncture groups are each treated by a similar number
of needles. Leaving this important point aside, we think
that the trial intervention protocol for acupuncture in the
ACUSAR trial represented an acceptable and feasible
compromise between an acupuncture treatment following
the rules of CM and the daily practice in Germany and the
standardisation need in clinical research.
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